European Journal of Dermatology
MENURisk behaviour and patient preferences for an improved non-melanoma skin cancer prevention modality for organ-transplanted patients: a European, multi-country, online patient community study Volume 29, numéro 5, September-October 2019
Auteurs
Background
1 Service de Dermatologie, Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010 Paris, France - Université Paris 7, 10 avenue de Verdun, 75010 Paris, France
2 Dermatology Department. Hospital Clínic de Barcelona, IDIBAPS, Carrer de Villarroel, 170, 08036, Barcelona, Spain–Universitat de Barcelona, Carrer de Casanova, 143, 08036 Barcelona, Spain
3 Pierre Fabre Laboratories, Dermatology innovation unit, Centre de Recherche et Développement, 3, avenue Hubert Curien - BP 13652, 31035 Toulouse, France
* Reprints
- Mots-clés : non-melanoma skin cancer, NMSC, organ transplantation, keratinocyte cancer, preventive treatment, skin protection
- DOI : 10.1684/ejd.2019.3639
- Page(s) : 518-23
- Année de parution : 2019
Immunosuppressants used in organ transplant patients increase the risk of non-melanoma skin cancer.